BR9807406A - Formulação farmacêutica, e, processo para a preparação das mesmas - Google Patents

Formulação farmacêutica, e, processo para a preparação das mesmas

Info

Publication number
BR9807406A
BR9807406A BR9807406-7A BR9807406A BR9807406A BR 9807406 A BR9807406 A BR 9807406A BR 9807406 A BR9807406 A BR 9807406A BR 9807406 A BR9807406 A BR 9807406A
Authority
BR
Brazil
Prior art keywords
pharmaceutical formulation
preparing
polysorbate
formulated
preparation
Prior art date
Application number
BR9807406-7A
Other languages
English (en)
Inventor
Bernard Abramovici
Xavier Boulenc
Jean-Claude Gautier
Pol Vilain
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of BR9807406A publication Critical patent/BR9807406A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

FORMULAçãO FARMACêUTICA, E, PROCESSO PARA A PREPARAçãO DAS MESMAS". As formulações farmacêuticas de acordo com a invenção contém 0,5 a 50 % em peso de um composto de amónio quaternário cíclico, e excipientes farmaceuticamente convenientes, e são formulados por granulação úmida, preferivelmente com polissorbato 80.
BR9807406-7A 1997-02-17 1998-02-17 Formulação farmacêutica, e, processo para a preparação das mesmas BR9807406A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701826A FR2759585B1 (fr) 1997-02-17 1997-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
PCT/FR1998/000299 WO1998035663A1 (fr) 1997-02-17 1998-02-17 Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique

Publications (1)

Publication Number Publication Date
BR9807406A true BR9807406A (pt) 2000-03-14

Family

ID=9503805

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9807406-7A BR9807406A (pt) 1997-02-17 1998-02-17 Formulação farmacêutica, e, processo para a preparação das mesmas

Country Status (18)

Country Link
US (1) US6303626B1 (pt)
EP (1) EP0981340B1 (pt)
JP (1) JP2001511796A (pt)
AR (1) AR011806A1 (pt)
AT (1) ATE210436T1 (pt)
AU (1) AU6405098A (pt)
BR (1) BR9807406A (pt)
CA (1) CA2281607A1 (pt)
CO (1) CO4920216A1 (pt)
DE (1) DE69802921T2 (pt)
DK (1) DK0981340T3 (pt)
ES (1) ES2172116T3 (pt)
FR (1) FR2759585B1 (pt)
HR (1) HRP980074A2 (pt)
NO (1) NO993927D0 (pt)
PT (1) PT981340E (pt)
WO (1) WO1998035663A1 (pt)
ZA (1) ZA981288B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151769A1 (en) * 2002-12-31 2004-08-05 Boehringer Ingelheim International Gmbh Film coated tablet containing an extract of red vine leaves
US20060210625A1 (en) * 2003-11-04 2006-09-21 Shire Laboratories, Inc. Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
CN102188424B (zh) * 2011-03-23 2013-03-27 浙江理工大学 Sr140333的抗血癌作用
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US20140271633A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Mammalian cell culture performance through surfactant supplementation of feed media
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5679693A (en) 1992-09-30 1997-10-21 Sanofi 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present
FR2696178B1 (fr) * 1992-09-30 1994-12-30 Sanofi Elf Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717804B1 (fr) 1994-03-25 1996-06-21 Sanofi Sa Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant.
FR2717802B1 (fr) * 1994-03-25 1996-06-21 Sanofi Sa Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant.
MX9701305A (es) * 1994-08-25 1998-05-31 Merrell Pharma Inc Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas.
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2725900B1 (fr) 1994-10-21 1997-07-18 Sanofi Sa Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
FR2729954B1 (fr) * 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr) 1995-01-30 1997-04-18 Sanofi Sa Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
DE69802921T2 (de) 2002-08-29
EP0981340B1 (fr) 2001-12-12
NO993927L (no) 1999-08-16
DE69802921D1 (de) 2002-01-24
US6303626B1 (en) 2001-10-16
CO4920216A1 (es) 2000-05-29
PT981340E (pt) 2002-05-31
FR2759585A1 (fr) 1998-08-21
ATE210436T1 (de) 2001-12-15
NO993927D0 (no) 1999-08-16
HK1023509A1 (en) 2000-09-15
EP0981340A1 (fr) 2000-03-01
AR011806A1 (es) 2000-09-13
WO1998035663A1 (fr) 1998-08-20
ZA981288B (en) 1998-08-26
FR2759585B1 (fr) 1999-06-11
ES2172116T3 (es) 2002-09-16
CA2281607A1 (en) 1998-08-20
JP2001511796A (ja) 2001-08-14
DK0981340T3 (da) 2002-03-25
AU6405098A (en) 1998-09-08
HRP980074A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
ATE330959T1 (de) Allosterische adenosin-rezeptor-modulatore
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
PT91246A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao endovenosa, contendo ciclosporina como ingrediente activo
SE8804629D0 (sv) New therapeutically active compounds
MX9201730A (es) Nuevos fenilazacicloalcanos substituidos que actuan centralmente.
PT655917E (pt) Composicoes de amifostina cristalina e metodos para a sua preparacao e utilizacao
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
PT82580B (pt) Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
BR9607965A (pt) Composto composição farmacêutica e processo para tratar uma doença parasítica em um mamífero
ES2053429T3 (es) El uso de buspirona para la preparacion de composiciones farmaceuticas para aliviar la ansiedad fobica.
BR9807406A (pt) Formulação farmacêutica, e, processo para a preparação das mesmas
PT88306A (pt) Processo para a preparacao de nucleosidos de 2', 3'-dideoxi-3'-fluoro-pirimidina e de composicoes farmaceuticas que os contem
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
CA2390558A1 (en) Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
BR9814498A (pt) Processo para o tratamento de obesidade em um humano necessitando de tal tratamento, composto, uso do mesmo, produto, e, composição farmacêutica
AU5714286A (en) Quinolylglycinamide derivatives,the process for preparation thereof and their therapeutic application as psychotropic drugs
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
HUP9802096A2 (hu) Piperidino-alkanol-vegyületeket tartalmazó orális adagolású oldat formájú gyógyszerkészítmény, és eljárás előállítására
BR8700191A (pt) Derivados de 2-alquilbenzimidazol,compostos,processo para a preparacao dos mesmos,composicoes farmaceuticas e utilizacao dos derivados
TR199900013T2 (xx) Yeni bile�ikler.
PT95810A (pt) Processo para a preparacao de composicoes farmaceuticas injectaveis contendo um alcaloide de bis-indol como ingrediente activo
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
PT989994E (pt) Derivados de estreptograminas, a sua preparacao e as composicoes que os contem

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1887 DE 06/03/2007.